The SLEEP 2026 Annual Meeting, held in Baltimore from June 14 to June 17, 2026, brought together thousands of researchers, clinicians, and sleep specialists. Jointly presented by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS), the conference highlighted significant research findings with direct implications for primary care.
Read More
A primary takeaway from the event was that chronic insomnia is not just a sleep quality issue but a cardiovascular risk factor. According to research published by the AASM, individuals with insomnia are at markedly higher risk for hypertension, heart failure, coronary artery disease, and stroke compared to those with normal sleep patterns. Disruptions to the hypothalamic-pituitary-adrenal (HPA) axis and increased sympathetic nervous system activity associated with chronic insomnia are believed to lead to detrimental changes in cardiovascular health. Notably, effective treatment of insomnia through Cognitive Behavioral Therapy for Insomnia (CBT-I) has been shown to improve cardiovascular biomarkers, including blood pressure.
Another critical finding is that Shift Work Sleep Disorder (SWSD), affecting 15-20% of the U.S. workforce, poses a heightened cardiovascular risk. New research indicates that shift workers face 2 to 3 times greater rates of hypertension and major cardiovascular events than day workers, yet less than 5% of those with SWSD receive adequate diagnosis or treatment.
In terms of treatment accessibility, digital CBT-I has emerged as a viable alternative to in-person therapy for chronic insomnia. Studies presented at the conference revealed that digital interventions like SleepioRx could significantly improve insomnia outcomes, making them easy for primary care physicians to prescribe.
The meeting also confirmed the expanded application of home sleep apnea testing (HSAT). Recent advancements have validated HSAT as an accurate diagnostic option for a broader range of patients, including those with hypertension and obesity. With 85-90% concordance with in-lab testing, physicians can now use a negative home sleep test as a conclusive assessment in appropriate cases.
Lastly, growing evidence links sleep architecture—specifically insufficient REM sleep and frequent sleep fragmentation—to increased dementia risk. This underscores the importance of addressing sleep quality, as disturbances in sleep could exacerbate cognitive decline and the development of dementia.
Overall, SLEEP 2026 underscored the integral role of sleep health in overall cardiovascular and cognitive function, providing actionable insights for primary care practices.